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Terpenoid metabolites are important to the cellular function, structural integrity, and patho-
genesis of the human-speciﬁc pathogen Mycobacterium tuberculosis (Mtb). Genetic and
biochemical investigations have indicated a role for the diterpenoid isotuberculosinol (isoTb)
early in the infection process. There are only two genes (Rv3377c and Rv3378c) required
for production of isoTb, yet these are found in what appears to be a ﬁve-gene ter-
penoid/isoprenoid biosynthetic operon. Of the three remaining genes (Rv3379c, Rv3382c,
and Rv3383c), previous work has indicated that Rv3379c is an inactive pseudo-gene. Here
we demonstrate that Rv3382c and Rv3383c encode biochemically redundantmachinery for
isoprenoid metabolism, encoding a functional 4-hydroxy-3-methylbut-2-enyl diphosphate
reductase (LytB) for isoprenoid precursor production and a geranylgeranyl diphosphate
(GGPP) synthase, respectively, for which the Mtb genome contains other functional
isozymes (Rv1110 and Rv0562, respectively). These results complete the characterization
of the isoTb biosynthetic operon, as well as further elucidating isoprenoid metabolism in
Mtb. In addition, we have investigated the evolutionary origin of this operon, revealingMtb-
speciﬁc conservation of the diterpene synthase genes responsible for isoTb biosynthesis,
which supports our previously advanced hypothesis that isoTb acts as a human-speciﬁc
pathogenic metabolite and is consistent with the human host speciﬁcity of Mtb. Intrigu-
ingly, our results revealed that many mycobacteria contain orthologs for both Rv3383c and
Rv0562, suggesting a potentially important role for these functionally redundant GGPP
synthases in the evolution of terpenoid/isoprenoid metabolism in the mycobacteria.
Keywords: isoprenoid biosynthesis, molecular evolution, virulence, terpenoids
INTRODUCTION
Each year, Mycobacterium tuberculosis (Mtb) accounts for ∼1.7
million deaths as the main causative agent of the human disease
Tuberculosis (Rohde et al., 2007), and the ability of this deadly
pathogen to inﬁltrate macrophage cells from the mammalian
immune system remains an active area of investigation (Rus-
sell, 2007). While the complete pathogenic mechanism remains
unknown, the bacteria appear to launch a multi-factorial attack
(Russell et al., 2010), with many bacterial genes involved in patho-
genesis (Joshi et al., 2006). Notably, a mutational screen for
genes involved in the early infection process highlighted a role
for Rv3377c and Rv3378c, loss of which reduced the ability of
Mtb to block acidiﬁcation of the engulﬁng phagosome compart-
ment, leading to suppressed bacterial proliferation in macrophage
cell cultures (Pethe et al., 2004). These genes have since been
characterized as encoding a pair of sequentially acting diter-
pene synthases responsible for the production of isotuberculosinol
(isoTb; Nakano et al., 2005a,b; Mann et al., 2009b; Maugel et al.,
2010; Prach et al., 2010; Spangler et al., 2010; Hoshino et al., 2011;
Mann et al., 2011b; Nakano et al., 2011), a diterpenoid capable
of arresting phagosomal maturation in vitro (Mann et al., 2009b).
Thus, isoTb appears to play an immunomodulatory role in the
Mtb infection process (Mann and Peters, 2012).
Rv3377c and Rv3378c fall within a larger operon that appears
to have been acquired via horizontal gene transfer before the
divergence of Mtb and Mycobacterium bovis (Becq et al., 2007).
The operon includes Rv3377c–Rv3383c, with the intervening
Rv3380c and Rv3381c representing apparent transposable ele-
ments inserted into a preexisting operon (Camus et al., 2002),
such that only ﬁve genes seem to be relevant. By homology, these
all appear to encode enzymes that could be involved in various
stages of isoTb production (Figure 1). However, only Rv3377c
and Rv3378c were isolated in the genetic screen targeting the early
infection process, despite the saturating nature of that study (Pethe
et al., 2004). The remaining genes do not appear to be required
for any essential cellular function, as indicated by previously
reported genetic screens (Sassetti et al., 2001, 2003; Sassetti and
Rubin, 2003; Joshi et al., 2006), leaving uncertain their function, if
any, in mycobacterial terpenoid biosynthesis. It has already been
reported that Rv3379c is an inactive pseudo-gene (Bailey et al.,
2002), leaving the function of the remaining genes in question.
Mycobacterium tuberculosis uses the methyl-erythritol-5-
phosphate (MEP) pathway for isoprenoid precursor biosynthesis
(Rohmer et al., 1993). The resulting 5-carbon isoprenyl isomers,
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate
(DMAPP), are then coupled together to form longer acyclic
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FIGURE 1 | Proposed isoTb biosynthetic operon.The ﬁve-gene
operon including the two previously characterized diterpene synthases
required for isoTb biosynthesis and the proposed roles of the remaining
uncharacterized genes in the biosynthetic pathway. Genes depicted in the
order suggested by their numbering rather than orientation of open reading
frame.
isoprenyl diphosphates such as the 10-carbon geranyl diphosphate
(GPP), 15-carbon farnesyl diphosphate (FPP), and 20-carbon
diterpenoid precursor geranylgeranyl diphosphate (GGPP). These
are then used in cell wall assembly (e.g., the further elongated
decaprenyl diphosphate), synthesis of other essential biomolecules
(e.g., menaquinone), as well as isoTb biosynthesis. In the
isoTb operon, Rv3379c is homologous to the deoxy-xylulose-
5-phosphate synthases that initiate the MEP pathway, and is
annotated as dxs2, although it has been reported to be an inac-
tive pseudo-gene (Bailey et al., 2002). Rv3382c encodes a putative
4-hydroxy-3-methylbut-2-enyl diphosphate reductase, the LytB
that catalyzes the ﬁnal step of theMEPpathway, producing IPP and
DMAPP (Rohdich et al., 2002), but this has not previously been
investigated. Rv3383c encodes a member of the isoprenyl diphos-
phate synthase (IDS) family, which generally catalyze isoprenyl
diphosphate chain elongation. Accordingly, the IDS encoded by
Rv3383c is likely to produce the GGPP required for isoTb biosyn-
thesis, but this also has not yet been investigated. Here, we
not only verify the biochemical function of both Rv3382c and
Rv3383c, but also the presence of robust isozymes catalyzing the
same reactions encoded elsewhere in the Mtb genome, suggest-
ing functional redundancy consistent with the reported genetic
screens. In addition, bioinformatics analysis of the available
mycobacterial genome sequences indicates asymmetric conserva-
tion of isoTb biosynthetic machinery in Mtb relative to the greater
Mycobacterium tuberculosis complex (MTC), consistent with a
previously hypothesized role for isoTb in the highly infectious
nature of Mtb in humans, along with the surprising ﬁnding of
wider conservation of dual GGPP synthases in a sub-group of
mycobacteria.
MATERIALS AND METHODS
GENERAL
All trans (E) isomers of GPP, FPP, and GGPP were pur-
chased from Isoprenoids, LC (Tampa, FL, USA). Unless oth-
erwise noted, all other chemicals were purchased from Fisher
Scientiﬁc (St. Louis, MO, USA) and all molecular biology
reagents were purchased from Invitrogen (Carlsbad, CA, USA).
Gas chromatography-ﬂame ionization (GC-FID) detection was
carried out using an Agilent 6890 GC-FID (Agilent Technologies,
Santa Clara, CA, USA) using a previously described method
(Schmidt and Gershenzon, 2008).
BIOINFORMATICS
Genes of interest were identiﬁed via basic local sequence align-
ment (BLAST) against the M. tuberculosis H37Rv genome (Cole
et al., 1998). Phylogenetic analysis of GGPP synthases (GGPPS)
was accomplished via UPGMAmodeling of amino acid sequences
(Sneath and Sokal, 1973), using CLC Sequence Viewer 6.0 (CLC
Bio, Cambridge, MA, USA). Complete operon analysis was per-
formed against publically available sequences of Mtb diversity
strains (Hershberg et al., 2008),M. canettii (Hershberg et al., 2008),
M. marinum (Stinear et al., 2008), and M. ulcerans (Stinear et al.,
2007), as well as previously published sequences of M. bovis
(Garnier et al., 2003), and M. bovis BCG (Brosch et al., 2007),
and the pre-publication reads of M. africanum (available via the
Sanger Institute). Genomic regions were aligned using BLAST
analysis and synteny mapping via the Tuberculosis Database
(Reddy et al., 2009).
CLONING
Genes of interest were cloned by PCR ampliﬁcation from Mtb
CDC1551 genomic DNA and conﬁrmed via complete sequencing.
These were transferred into pENTR/SD/D-TOPO (Gateway, Invit-
rogen) by directional recombination. Rv2173 and Rv0562 were
modiﬁed to change the ﬁrst codon to ATG to enable expression in
Escherichia coli, for which purpose all genes were recombined into
pDEST17 expression vectors for production with an N-terminal
6xHis tag.
LytB COMPLEMENTATION
LytB complementation was initially assessed by colony count-
ing assays, carried out in three individual experiments, each in
duplicate. 50 ng of plasmid (pDEST14) containing Rv3382c or
Rv1110 were each electroporated into 100 μL electro-competent
E. coli cells containing LytB under arabinose promoter control
(McAteer et al., 2001) and were plated on NZY medium in the
absence of arabinose, which allows only for growth of LytB
complemented cells. Electroporated E. coli cells plated in the
presence and absence of 0.2% arabinose were used as controls.
Frontiers in Microbiology | Evolutionary and Genomic Microbiology October 2012 | Volume 3 | Article 368 | 2
“fmicb-03-00368” — 2012/10/10 — 20:21 — page 3 — #3
Mann et al. The Mycobacterium tuberculosis isotuberculosinol operon
More quantitative analysis of LytB activity was accomplished by
comparison of relative growth rates, carried out in triplicate.
Colonies from Plasmid (+) plates were grown to saturation in
LB medium overnight. Cultures were diluted 1/100 into fresh LB
medium containing 0.5 mM isopropylthiogalactoside (IPTG) and
grown for 1 h, then diluted 1/50 into media containing 50 μg/mL
carbenicillin and 0.2% (v/v) glucose to inhibit the arabinose pro-
moter and thus completely inhibit any expression of E. coli LytB.
After 220 min, cultures were diluted 1/50 into medium contain-
ing 0.2% (v/v) arabinose, thus activating the chromosomal LytB
and allowing for comparative analysis of the relative health of
both complemented strains (i.e., to demonstrate that expression
of Rv3382c did not exert any toxicity relative to expression of
Rv1110 instead). Culture growth was monitored every 20 min by
measuring OD600.
PUTATIVE GGPP SYNTHASE EXPRESSION
Putative GGPP synthases in pDEST17 were transformed into the
C41 strain of E. coli (Lucigen,Middleton,WI,USA), and plated on
NZY agar with carbenicillin (50 μg/mL) selection. Colonies were
inoculated in 50 mL of NZY medium and grown to an optical
density at 600 nm (OD600) of 0.6 at 37◦C before being trans-
ferred to 16◦C for 1 h prior to induction with 0.5 mM IPTG, with
subsequent 14–16 h incubation. Cells were harvested via centrifu-
gation and lysed in 1 mL lysis buffer (10 mM Tris-Cl, pH 6.8, 10%
glycerol, 1 mM dithiothreitol) via sonication. These lysates were
clariﬁed via centrifugation (10 min × 10,000g) and the result-
ing cell free extracts assayed for GGPP synthase activity. As E.
coli does not harbor contaminating GGPP synthases (Burke and
Croteau, 2002), any resulting production of GGPP was attributed
to expression of the recombinant gene.
GGPP SYNTHASE ASSAY
Assay buffer (50 mM sodium phosphate (pH 7.0), 10% glycerol,
5mMMgCl2, 1mMdithiothreitol)wasmixedwith 20μMIPPand
the equivalent concentration of indicated allylic isoprenyl diphos-
phate. To each assay, 100 μL of puriﬁed protein (∼1 mg/mL)
expressed as a 6×His fusion in pDEST17 was added, totaling
1 mL total volume. Assays were conducted at 37◦C for indi-
cated time and halted via incubation at 100◦C for 5 min. After
cooling, 1.5 U calf intestinal alkaline phosphatase (New England
Biolabs, Ipswich,MA,USA) was added according tomanufacturer
protocol. The phosphatase reaction was incubated overnight at
37◦C and extracted thrice with 1 mL hexanes. Samples were con-
centrated and analyzed via GC-FID and compared to similarly,
dephosphorylated authentic GGPP.
KINETIC ANALYSIS OF Rv3383c AND Rv0562
The 6×His tagged versions of these enzymes were puriﬁed via
Ni-NTA Superﬂow resin (Novagen, Merck, Germany) following
the manufacturer directions. Protein was analyzed via denatur-
ing gel electrophoresis (SDS-PAGE), demonstrating>90% purity.
Enzymes were assayed as described against a substrate gradient
(0–40 μM) with IPP and DMAPP/FPP for 5 min with 100 nM
enzyme. Post-extraction, cembrene was added to a ﬁnal concen-
tration of 5μMas an internal standard for quantiﬁcation. Product
concentration was calculated by integration of the product peak
area and comparison to internal standard peak area. Michaelis–
Menten curves were ﬁt to the observed data (KaleidaGraph 4.0,
Synergy Software, Reading, PA,USA), resulting inR2 values≥0.95.
RESULTS
POTENTIAL ISOZYMES FOR BOTH Rv3382c AND Rv3383c
To begin investigating the hypothesized biochemical redundancy,
the uncharacterized Rv3382c and Rv3383c were analyzed and
compared to the rest of the Mtb genome. Rv3382c is 990 bp long
and encodes a protein of 329 amino acids (AA) that has been
annotated as lytB1, while Rv3383c is 1053 bp long and encodes
a 350 AA protein annotated as idsB (Camus et al., 2002). Both
genes are non-essential (Sassetti et al., 2003), and neither is associ-
ated with pathogenicity in published genetic screens (Sassetti and
Rubin, 2003; Pethe et al., 2004; Fortune et al., 2005; Joshi et al.,
2006). Protein–protein BLAST analysis of Rv3382c and Rv3383c
against the H37Rv genome revealed putative paralogs for both.
Speciﬁcally, Rv3382c shares 50% AA identity with Rv1110, which
is similarly annotated as lytB2 (Camus et al., 2002). There are four
IDS paralogs to Rv3383c in the Mtb genome: Rv3398c, a previ-
ously identiﬁed FPP synthase annotated as idsA1 (Dhiman et al.,
2004),which shares 35%AA identitywithRv3383c; Rv2173, anno-
tated as idsA2, which shares 29% AA identity; Rv0562, annotated
asgrcC1, which shares 30% AA identity; and Rv0989c, that we
have recently demonstrated encodes a functional GPP synthase
likely involved in decaprenyl diphosphate biosynthesis (Mann
et al., 2011a), annotated as grcC2, which shares 28% AA identity.
FUNCTIONAL ANALYSIS OF Rv3382c AND Rv1110
LytB is a [4Fe–4S] protein that has been shown to be difﬁcult
to work with in vitro, due to complications from both oxygen
corruption and substrate availability (Adam et al., 2002; Wolff
et al., 2003). Accordingly, such enzymatic activity is most often
demonstrated by a complementation approach (McAteer et al.,
2001; Rohdich et al., 2002; Hsieh and Goodman, 2005). Brieﬂy,
this utilizes a previously developed strain of E. coli in which the
endogenous LytB gene (EG11081) has been put under control
of an arabinose promoter, such that bacterial growth requires
either supplementationwith arabinose or complementationwith a
functional LytB (McAteer et al., 2001). Both Rv3382c and Rv1110
were able to complement the growth of this strain of E. coli in
the absence of arabinose, demonstrating functional LytB activ-
ity. Relative growth rate analysis indicates that complementation
with Rv3382c results in somewhat less vigorous growth than does
complementation with Rv1110, which does not appear to be
due to a toxicity effect (Figure 2). This result then suggests that
Rv3382c exhibits somewhat less robust LytB activity than Rv1110,
which might be due to Rv3382c being 8 AA shorter at the N-
terminus. However, this region does not contain any residues
known to be involved in enzymatic activity, and the exact mecha-
nismunderlying reduced function of the LytB encoded byRv3382c
is unclear.
ANALYSIS OF PUTATIVE GGPP SYNTHASES
The production of GGPP is catalyzed by the condensation of
IPP with allylic isoprenyl diphosphate acceptors, such as DMAPP
(which then requires the addition of three molecules of IPP), GPP
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FIGURE 2 | Complementation assay for LytB activity. Growth curve of
lytB− E. coli complemented with Rv1110 (circles) or Rv3382c (squares).
These bacteria were grown to saturation, then diluted 1/100 into fresh
media containing 0.5 mM IPTG. After 60 min, cultures were diluted 1/50 in
media containing selective antibiotic and 0.02% glucose (to suppress
endogenous LytB expression). After 220 min, cultures were diluted 1/100 in
media containing selective antibiotic, but 0.2% arabinose instead of
glucose, which activated expression of the endogenous LytB, to
demonstrate that the Rv3382c gene itself did not have any deleterious
effects (i.e., as both recombinant strains then exhibited equivalent growth).
(e.g., that produced by Rv0989c, which then requires the addition
of two molecules of IPP), or FPP (e.g., that produced by Rv3398c,
which then only requires the addition of a single molecule of IPP;
Figure 3). Thus, the putative GGPP synthases identiﬁed above
were screened for such activity by assaying puriﬁed recombinant
proteins expressed in E. coli, in the presence of IPP plus DMAPP,
GPP, or FPP (Table 1). Both Rv0562 and Rv3383c were able to add
IPP to FPP, producing GGPP (Figure 4). In addition, Rv0562 is
able to produce GGPP using either DMAPP, GPP, or FPP as the
allylic precursor, while Rv3383c can synthesize GGPP only when
fed FPP (Table 1). By contrast, Rv2173 only exhibited intermittent
GGPP synthase activity in these assays, indicating that its primary
product may not be GGPP. Further studies are ongoing with this
enzyme to clarify its function.
EVOLUTION OF THE isoTb OPERON WITHIN THE MYCOBACTERIA
The commonly accepted evolutionary scheme for pathogenic
mycobacteria indicates that the MTC emerged from a common
ancestor, which was most recently shared with M. canettii, to cre-
ate a pool of human and animal pathogens, includingM. bovis and
M. africanum, along with Mtb (Brosch et al., 2002). Early analysis
of the Mtb genome isolated a putative ﬁve-gene operon involved
in isoprenoid biosynthesis at coordinates 3790.85–3799.64 kb and
containing loci Rv3377–Rv3383c. This operon was identiﬁed as
OPP OPP
Rv0989c
OPP
OPP
Rv3398c
OPP
Rv0562
Rv3383c
Rv3398c
Rv0562
Rv0562
+
IPP DMAPP
GPP
GGPP
FPP
2 x IPP
2 x IPP
3 x IPP
+IPP
+IPP
FIGURE 3 | Substrate plasticity of GGPPS. GGPPS enzymes are
sometimes able to utilize a variety of substrates to synthesize the
20-carbon product, GGPP. Outlined are the various biosynthetic pathways
for GGPP production in Mtb.
potential horizontal gene transfer products from an exogenous
source due to aberrations in GC content within this region (Becq
et al., 2007). Rv3377c and Rv3378c are diterpene synthases that
produce the immunomodulatory diterpenoid isoTb via cycliza-
tion of the diterpenoid precursor GGPP (Nakano et al., 2005a,b;
Mann et al., 2009b; Maugel et al., 2010; Prach et al., 2010; Spangler
et al., 2010; Hoshino et al., 2011; Mann et al., 2011b; Nakano et al.,
2011). In our characterization of the diterpene cyclase encoded
by Rv3377c, we noted that this gene was conserved in all four of
the Mtb strains whose genomes were available at that time, while
the M. bovis homolog contained an inactivating frameshift muta-
tion that was conserved in the two sequenced strains, along with
another that we investigated (Mann et al., 2009a). Based on the
wider host range, but reduced infectivity in humans, of M. bovis,
we then speculated that isoTb might play a role in the highly
infectious nature of Mtb in humans. Given the current availabil-
ity of genome sequences from a number of diverse Mtb strains
Table 1 | Kinetic analysis of confirmed GGPP synthases.
Enzyme IPP DMAPP GPP FPP
KM (μM) kcat (min−1) KM (μM) kcat (min−1) KM (μM) kcat (min−1) KM (μM)
Rv0562 1.7 ± 0.7 0.17 ± 0.02 5 ± 2 0.3 ± 0.2 2.3 ± 0.8 0.7 ± 0.1 11 ± 3
Rv3383c 11 ± 2 NR NR NR NR 1.0 ± 0.5 19 ± 5
NR, no reaction.
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FIGURE 4 | Production of GGPP by Rv3383c and Rv0562. GC-FID
chromatogram of GGPP-derived GGOH production in Rv0562 and Rv3383c,
but not the previously conﬁrmed (E,E )-FPP synthase Rv3398c, as
compared to dephosphorylated authentic standard.
(Comas et al., 2010), as well as several members of the MTC and
other mycobacteria (Reddy et al., 2009), these were analyzed for
the presence of all or part of the isoTb operon. Corresponding
sequences could be found not only in the MTC and M. canettii,
but also the much more distantly related M. marinum, although
it is not present in the even more distantly related M. leprae, sug-
gesting that the isoTb operon was acquired prior to separation
of the lineages leading to M. marinum and the MTC/M. canet-
tii. We further characterized the existing polymorphisms of not
only the diterpene synthases [i.e., Rv3377c and Rv3378c, as pre-
viously reported (Mann and Peters, 2012)], but also the entire
isoTb operon in these mycobacteria. Notably, very few muta-
tions are found within the unique diterpene synthase encoding
genes (i.e., Rv3377c and/or Rv3378c) in the sequenced strains of
Mtb (Comas et al., 2010), with none in the highly infectious Bei-
jing subgroup. By contrast, the other species within the MTC,
as well as M. canettii, all have accrued frameshift and/or non-
synonymous mutations in Rv3377c or Rv3378c. The range of
observedmutations in these diterpene synthases is consistent with
the current view of mycobacteria evolution, with only a single
non-synonymous mutation found in the more recently derived
M. africanum. By contrast, the more distantly related M. canet-
tii contains both non-synonymous and frameshift mutations,
wherein the frameshift mutation presumably precludes synthesis
of isoTb,much as we previously demonstrated forM. bovis (Mann
et al., 2009a). In addition, the much earlier diverging M. marinum
does not contain the diterpene synthase genes at all, although it
does have the other genes from this operon. Speciﬁcally, M. mar-
inum has retained orthologs to the GGPP synthase encoded by
Rv3383c, the LytB encoded by Rv3382c, and the pseudo-DXS
encoded by Rv3379c, although there also has been an apparent
transposon-mediated insertion within the operon. We suggest
that this reﬂects loss of the diterpene synthases, rather than their
later addition in the M. canettii/MTC lineage, as it is unclear why
the other genes, which together produce the diterpene precur-
sor GGPP, would have been assembled together in the absence
of the downstream diterpene synthases (and prior to the acqui-
sition of the carotenoid biosynthetic machinery, i.e., as seen in
M.marinum). In the genome of M. ulcerans, which is derived from
M. marinum (Stinear et al., 2007), the operon has been further
reduced, with only the Rv3383c ortholog remaining (Figure 5).
While this observation is consistent with the previously noted
severe genome reduction of M. ulcerans (Stinear et al., 2000),
M. marinum is believed to have undergone parallel evolution
from a common ancestor with Mtb, but is generally considered
to have retained and incorporated more genes, as expected for a
more general pathogen, relative to the human host restricted Mtb
(Stinear et al., 2007). Accordingly, isoTb production seems to be
most highly conserved in Mtb, despite its comparatively special-
ized genome, which is consistent with our previous speculation
positing a role for isoTb in the highly infectious nature of this
human-speciﬁc pathogen (Mann and Peters, 2012).
CONSERVATION OF GGPP SYNTHASES WITHIN THE MYCOBACTERIA
Although the ability to produce isoTb has not been found and
seems unlikely to occur outside of Mtb, it is notable that the
GGPP producing IDS found in Mtb are subject to stronger con-
servation (Figure 6). Strikingly, the GGPP synthase encoding
Rv3383c/idsB from the isoTb operon was retained even through
the reductive evolution process leading to M. ulcerans where the
remainder of the operon is lost (Figure 5). While the presence of
a GGPP synthase is likely due to its role in production of carriers
involved in cell wall synthesis, the retention of multiple GGPP syn-
thases in these mycobacteria is striking, albeit somewhat puzzling.
Rv0562/grcC1 is likely the ancestral GGPP synthase and is widely
found in the family Mycobacterium, e.g., an ortholog is present in
the fast-growing, non-pathogenic saprophyteM. smegmatis. How-
ever, those mycobacteria derived from the MTC and M. marinum
ancestral strain also have retained the additional GGPP synthase
encoded by Rv3383c/idsB, even upon loss of the other genes in the
isoTb operon (e.g., in M. ulcerans). In the case of M. marinum,
this might be due to its production of GGPP-derived carotenoids
(Ichiyama et al., 1988), although M. marinum also has acquired
multiple other IDS homologs. In any case, this rationale does not
hold true for other mycobacteria, leaving unclear what selective
pressure led to the wider conservation of Rv3383/idsB noted here.
Interestingly, this speciﬁc conservation of dual GGPP synthase
homologs across these diverse species of mycobacteria suggests a
more signiﬁcant role for GGPP than previously presumed, consis-
tent with the previous observation of large pools of GGPP-derived
geranylgeraniol in Mtb cellular extracts (Crick et al., 2000; Mann
et al., 2011b). However, it should be noted that the increased
sequence divergence of theRv3383c/idsB orthologs inM.marinum
and M. ulcerans also might reﬂect functional diversiﬁcation.
DISCUSSION
Mycobacterium tuberculosis is a persistent and deadly human
pathogen whose ability to inﬁltrate and spread within the human
immune system has led to intense interest in all aspects of its life
cycle (Russell et al., 2010). Isoprenoid metabolites play a variety
of roles in Mtb and other bacteria, including electron transfer
components and cell wall biosynthesis (Daum et al., 2009). At
least in the case of Mtb, this appears to extend to its pathogenic
lifestyle (Dhiman et al., 2004; Kaur et al., 2004; Holsclaw et al.,
2008; Mann et al., 2009b). In particular, the bioactive diterpenoid
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FIGURE 5 | Conservation of the isoTb operon in the MTC and closely
related mycobacteria. Analysis of the isoTb operon in the context of wider
mycobacterial evolution indicates the operon was likely acquired in the most
recent common ancestor to the MTC and M. marinum. The functional genes
in the operon (light gray arrows) were retained during the speciation events
leading to M. canetti, Mtb, M. africanum, and M. bovis, following which the
operon independently evolved in each species, as evidenced by unique
insertion–deletion and/or non-synonymous mutations in the diterpene
synthases (black bars). Further, following separation of M. marinum
and the MTC, the diterpene synthases were lost from M. marinum and
several genes inserted, thus disrupting the operon. During later reductive
speciation leading to M. ulcerans, two of the remaining genes were lost,
leaving only the homolog to Rv3383c and ﬂanking segments of the
genome. Notably, retention of fully functional diterpene synthase
encoding genes (Rv3377c and Rv3378c) is only found in the human-speciﬁc
pathogen Mtb.
isoTb seems to contribute to early processes in Mtb infections,
based on both its biological activity (Mann et al., 2009b), and the
reduced proliferation of Mtb unable to produce isoTb (Pethe et al.,
2004). Moreover, speciﬁc conservation of the requisite diterpene
synthases Rv3377c and Rv3378c in Mtb relative to the rest of the
species in theMTC (Figure 5), has led to the suggestion that isoTb
may play a role in the highly infectious nature of Mtb in humans
(Mann andPeters, 2012),making this a potentially human-speciﬁc
pathogenic natural product.
The two diterpene synthases required for isoTb biosynthesis
were isolated in a screen for genes contributing to the early infec-
tion process. However, while the identiﬁed Rv3377c and Rv3378c
are found in a larger ﬁve-gene operon, the remaining three genes
were not isolated in this genetic screen, despite its saturating nature
(Pethe et al., 2004). Presumably, these three genes originally func-
tioned to increase ﬂux into and through the MEP isoprenoid
precursor pathway (i.e., Rv3379c/dxs2 and Rv3382c/lytB1), as
well as direct it toward diterpenoid biosynthesis via production
of GGPP (i.e., Rv3383c/idsB). This would enable production of
isoTb by the accompanying diterpene synthases (i.e., Rv3377c and
Rv3378c). While the isoTb operon appears to have been acquired
via horizontal gene transfer prior to the speciation of Mtb and
M. bovis (Becq et al., 2007), its presence in M. canettii demon-
strates even earlier acquisition. Moreover, the presence of several
of these genes inM. marinum suggests that the operon was present
in the last common ancestor of the MTC/M. canettii and M. mar-
inum. In any case, Rv3379–Rv3383c appear to be functionally
redundant as none of these genes is essential in Mtb (Sassetti et al.,
2001, 2003; Sassetti andRubin, 2003; Joshi et al., 2006), nor do they
appear to be absolutely required for isoTb production (Pethe et al.,
2004). Consistent with this hypothesis it was previously reported
that Rv3379c is an inactive pseudo-gene (Bailey et al., 2002).
It had already been predicted that the Mtb genome encodes
two functional LytB for the MEP isoprenoid precursor path-
way (Camus et al., 2002), and our studies conﬁrm that both
Rv1110/lytB2 and Rv3382c/lytB1 exhibit such activity (Figure 2).
Given the non-essential nature of either of these genes indicated
by previously reported genetic screens (Sassetti et al., 2001, 2003;
Sassetti and Rubin, 2003; Joshi et al., 2006), our results indicate
that Rv1110 and Rv3382c are functionally redundant. The essen-
tial nature of isoprenoidmetabolism, alongwith the sole use of the
distinct MEP pathway for precursor supply in bacteria indicates
that the enzymes mediating this process might provide good tar-
gets for development of antibacterial agents (Singh et al., 2007; Eoh
et al., 2009; Obiol-Pardo et al., 2011). However, it should be noted
that, despite their analogous activity, the LytB paralogs character-
ized here share only 50%AA identity, and such divergence suggests
that it may be difﬁcult to simultaneously inhibit both gene prod-
ucts, i.e., to pharmaceutically block this step of the MEP pathway
in Mtb.
Our results further demonstrate that Mtb contains two GGPP
synthases, encoded by Rv3383c/idsB and Rv0562/grcC1 (Table 1
and Figure 3). Given the non-essential nature of Rv3383c indi-
cated by previously reported genetic screens (Sassetti et al., 2001,
2003; Sassetti and Rubin, 2003; Joshi et al., 2006), our results sug-
gest that Rv3383c is functionally redundant. By contrast, Rv0562
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FIGURE 6 | Conservation of GGPP synthases in the MTC and closely
related mycobacteria. GGPP synthases appear to have assumed
additional wider importance in mycobacteria, as evidenced by the retention
of Rv3383c/idsB despite loss of the remaining isoTb operon. Retention of
orthologs for both Rv3383c/idsB and Rv0562/grcC1, based on both
sequence similarity and genome positioning, is found in all sequenced
members of the Mycobacterium family derived from the last common
ancestor of the MTC and M. marinum. Species designated by genus and
species initials (i.e., Mt, M. tuberculosis; Mb, M. bovis; Ma, M. africanum;
Mc, M. canettii ; Mm, M. marinum; Mu, M. ulcerans; Ml, M. leprae; Ms, M.
smegmatis) and genes as annotated in the Mtb genome (i.e., either grcC1
or idsB), with the next closest ids homolog from M. smegmatis shown as
the outgroup sequence). Not that while many of the listed species do
contain other IDS encoding genes, these are relatively distantly related to
those shown here.
has been found to be essential in Mtb (Sassetti et al., 2003). Its
ancestral function presumably was to initiate the production of
long chain isoprenylated carriers required for cell wall assembly,
as this is derived from GGPP in mycobacteria other than Mtb
(Besra et al., 1994), and Rv0562 is extremely well conserved in
the mycobacterial family (Figure 6). However, Mtb uses (Z,E)-
FPP instead of GGPP as the precursor for cell wall isoprenylated
carrier biosynthesis (Schulbach et al., 2000). Thus, particularly
since Rv0562 is located just downstream of genes encoding other
menaquinone biosyntheticmachinery in theMtb genome (Camus
et al., 2002), we hypothesize that it may instead be required for
generation of GGPP for production of this essential electron car-
rier, presumably as precursor to the known longer chain isoprenyl
sidechain (Holsclaw et al., 2008). As an alternative and/or supple-
mental rationale for the essential nature of Rv0562, our results
indicate that this gene encodes a GGPP synthase with more robust
and enzymatic activity than that encoded by Rv3383c (i.e., that
encoded by Rv0562 can produce GGPP from any length allylic
precursor, rather than being limited to FPP as is the IDS encoded
by Rv3383c).
In conclusion, our results clarify not only the role of all the genes
in the operon associated with isoTb biosynthesis, but also previ-
ous metabolic, biochemical, and genetic observations regarding
isoprenoid metabolism in Mtb, as described above. Nevertheless,
there are questions that arise from the results reported here, such as
the role of the remaining uncharacterized IDS in theMTC, and the
puzzling observation of widespread conservation of Rv3383c/idsB,
presumably encoding a second GGPP synthase, in mycobacteria,
which we hope to address in future studies.
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